bioAffinity Technologies, Inc. (BIAF) NASDAQ
2.12
+1.05(+98.13%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
2.12
+1.05(+98.13%)
Currency In USD
| Market Cap | 2.03M |
| Enterprise Value | -3.26M |
| P/E Ratio | -0.11 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 1.55 |
| Price/Book Ratio | 0.23 |
| Enterprise/Revenue | 0.69 |
| Enterprise/EBITDA | -0.42 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -2.42 |
| Operating Margin | -1.72 |
| Return On Assets | -1.36 |
| Return On Equity | -3.85 |
| Revenue | 6.16M |
| Revenue/Share | 7.67 |
| Gross Profit | 1.43M |
| EBITDA | -10.07M |
| Net Income | -14.91M |
| Diluted EPS | -8.66 |
| Total Cash | 6.45M |
| Total Cash/Share | 8.03 |
| Total Debt | 1.16M |
| Total Debt/Equity | 0.16 |
| Current Ratio | 2.6 |
| Book Value Per Share | 9.06 |
| 52-Week Change | -80.74 |
| 52-Week High | 46.53 |
| 52-Week Low | 0.69 |
| Moving Average 50 Days | 1.16 |
| Moving Average 200 Days | 4.45 |
| Average Volume | 4.44M |
| Shares Outstanding | 4.5M |
| % Held by Institutions | 3.12 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
| Last Split Date | September 19, 2025 |